SAN JOSE, Sept. 6, 2023 /PRNewswire/ — Teikoku Pharma USA, a global pharmaceutical company, today announced positive topline results from its Phase 2 proof of concept study of TPU-006, a 4-day dexmedetomidine transdermal patch for Post Surgical Pain. The double-blind, placebo-controlled, single-dose study evaluated the analgesic efficacy and safety of…Read More
Latest News Teikoku Pharma USA announces positive topline results from Phase 2 clinical trial of TPU006 non opioid pain management patch in Abdominoplasty Surgery Businessfortnight
